Similar articles

• Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region.

  Evans DB, Wolff RA, Hess KR. Evans DB, et al. Ann Surg. 2000 Nov;232(5):727. doi: 10.1097/00000658-200011000-00028. Ann Surg. 2000. PMID: 11066157 Free PMC article. No abstract available.
• Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region.

  Hoffman JP. Hoffman JP. Ann Surg. 2000 Nov;232(5):726-7. doi: 10.1097/00000658-200011000-00027. Ann Surg. 2000. PMID: 11066156 Free PMC article. No abstract available.
• Adjuvant therapy following surgery for periampullary and pancreatic cancers.

  Sonkar AA, Poston GJ. Sonkar AA, et al. Eur J Surg Oncol. 2004 Nov;30(9):911-2. doi: 10.1016/j.ejso.2004.07.011. Eur J Surg Oncol. 2004. PMID: 15498632 No abstract available.
• Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003.

  Abrams RA, Yeo CJ. Abrams RA, et al. Surg Oncol Clin N Am. 2004 Oct;13(4):621-38, ix. doi: 10.1016/j.soc.2004.06.004. Surg Oncol Clin N Am. 2004. PMID: 15350938 Review.
• The case for routine use of adjuvant therapy in pancreatic cancer.

  Kennedy EP, Yeo CJ. Kennedy EP, et al. J Surg Oncol. 2007 Jun 1;95(7):597-603. doi: 10.1002/jso.20719. J Surg Oncol. 2007. PMID: 17230543 Review.